$NROM
NOBLE ROMANS INC Stock $nrom

$nrom Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000165495424006563 Filed on May 17, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$3.666M	$3.334M	$14.37M
YoY Change	10.83%	0.14%	-0.55%
Cost Of Revenue	$2.547M	$2.393M	$8.837M
YoY Change	118.11%	-21.35%	-22.53%
Gross Profit	$1.119M	$941.1K	$5.536M
YoY Change	-47.7%	228.3%	81.76%
Gross Profit Margin	30.53%	28.23%	38.52%
Selling, General & Admin	$577.3K	-$15.56K	$1.549M
YoY Change	11.27%	-102.73%	-28.55%
% of Gross Profit	51.58%	-1.65%	27.98%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$212.1K	-$260.5K	$379.5K
YoY Change	5.37%	-210.4%	-59.75%
% of Gross Profit	18.95%	-27.68%	6.86%
Operating Expenses	$2.547M	$245.5K	$8.837M
YoY Change	118.11%	-63.98%	-22.53%
Operating Profit	$432.2K	$695.6K	$3.440M
YoY Change	-71.67%	-276.16%	704.2%
Interest Expense	$394.2K	-$623.0K	$1.744M
YoY Change	2.84%	11.52%	7.27%
% of Operating Profit	91.2%	-89.56%	50.72%
Other Income/Expense, Net	-$124.5K	-$234.9K	-$234.9K
YoY Change
Pretax Income	-$86.48K	-$162.3K	$1.460M
YoY Change	-107.57%	-82.98%	-221.84%
Income Tax	$0.00	-$274.2K	$0.00
% Of Pretax Income			0.0%
Net Earnings	-$86.48K	$111.9K	$1.460M
YoY Change	-109.96%	-112.82%	-238.28%
Net Earnings / Revenue	-2.36%	3.36%	10.16%
Basic Earnings Per Share	$0.00		$0.07
Diluted Earnings Per Share	$0.00	$0.00	$0.06
COMMON SHARES
Basic Shares Outstanding	22.22M shares	22.22M shares	22.22M shares
Diluted Shares Outstanding	22.22M shares		23.60M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.165M	$872.3K	$872.3K
YoY Change	151.49%	11.05%	11.05%
Cash & Equivalents	$1.165M	$872.3K
Short-Term Investments
Other Short-Term Assets	$280.7K	$318.2K	$318.2K
YoY Change	-30.06%	-25.1%	-25.1%
Inventory	$999.6K	$965.8K	$965.8K
Prepaid Expenses	$280.7K	$318.2K
Receivables	$720.3K	$1.169M	$1.169M
Other Receivables	$507.7K	$507.7K	$507.7K
Total Short-Term Assets	$3.673M	$3.834M	$3.834M
YoY Change	-12.18%	26.42%	26.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.242M	$4.320M	$9.250M
YoY Change	-8.39%	-8.35%	-10.83%
Goodwill	$278.5K	$278.5K
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.782M	$4.778M	$4.778M
YoY Change	18.26%	10.89%	10.89%
Total Long-Term Assets	$14.33M	$18.48M	$14.65M
YoY Change	-3.25%	20.7%	-4.34%
TOTAL ASSETS
Total Short-Term Assets	$3.673M	$3.834M	$3.834M
Total Long-Term Assets	$14.33M	$18.48M	$14.65M
Total Assets	$18.01M	$18.48M	$18.48M
YoY Change	-5.22%	0.74%	0.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.089M	$1.284M	$1.284M
YoY Change	81.89%	97.39%	97.39%
Accrued Expenses	$817.4K	$799.2K	$799.2K
YoY Change	2.28%	0.0%	0.0%
Deferred Revenue
YoY Change
Short-Term Debt	$575.0K	$0.00	$0.00
YoY Change
Long-Term Debt Due	$7.029M	$1.000M	$1.000M
YoY Change	602.85%	15.38%	15.38%
Total Short-Term Liabilities	$10.18M	$3.624M	$3.624M
YoY Change	324.33%	56.45%	56.45%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$6.709M	$6.709M
YoY Change	-100.0%	-17.11%	-17.11%
Other Long-Term Liabilities	$5.724M	$5.956M	$5.956M
YoY Change	-3.04%	-1.82%	-1.82%
Total Long-Term Liabilities	$5.724M	$12.66M	$12.66M
YoY Change	-58.7%	-10.56%	-10.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.18M	$3.624M	$3.624M
Total Long-Term Liabilities	$5.724M	$12.66M	$12.66M
Total Liabilities	$15.90M	$16.29M	$16.29M
YoY Change	-2.2%	-1.14%	-1.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$22.74M	-$22.65M
YoY Change	2.95%	-1.32%
Common Stock	$24.84M	$24.84M
YoY Change	0.07%	0.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.107M	$2.191M	$2.191M
YoY Change
Total Liabilities & Shareholders Equity	$18.01M	$18.48M	$18.48M
YoY Change	-5.22%	0.74%	0.74%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$86.48K	$111.9K	$1.460M
YoY Change	-109.96%	-112.82%	-238.28%
Depreciation, Depletion And Amortization	$212.1K	-$260.5K	$379.5K
YoY Change	5.37%	-210.4%	-59.75%
Cash From Operating Activities	$561.6K	$508.6K	$1.569M
YoY Change	-392.13%	7558.89%	5202.02%
INVESTING ACTIVITIES
Capital Expenditures	$18.83K		$13.83K
YoY Change	41.21%		-97.28%
Acquisitions
YoY Change
Other Investing Activities		$13.83K	$13.83K
YoY Change
Cash From Investing Activities	-$18.83K	$43.83K	$13.83K
YoY Change	41.21%	22.12%	-102.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$250.0K	-245.6K	-$1.496M
YoY Change	114.29%
NET CHANGE
Cash From Operating Activities	$561.6K	508.6K	$1.569M
Cash From Investing Activities	-$18.83K	43.83K	$13.83K
Cash From Financing Activities	-$250.0K	-245.6K	-$1.496M
Net Change In Cash	$292.7K	306.8K	$86.81K
YoY Change	-190.85%	621.42%	-118.16%
FREE CASH FLOW
Cash From Operating Activities	$561.6K	$508.6K	$1.569M
Capital Expenditures	$18.83K		$13.83K
Free Cash Flow	$542.7K		$1.555M
YoY Change	-364.01%		-425.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000709005
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.00
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.00
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22215512	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22215512	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22215512	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2023Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	802000.000	usd
CY2023Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	5000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3400000.0	usd
CY2023	nrom	Taxable Effective Tax Rate TaxableEffectiveTaxRate	0.24	pure
CY2023	nrom	State And Federal Income Tax Rate StateAndFederalIncomeTaxRate	0.24	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	0-11104
CY2023	dei	Entity Registrant Name EntityRegistrantName	NOBLE ROMAN’S, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	IN
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	35-1281154
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	6612 E
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	75th Street
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	Suite 450
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Indianapolis
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	IN
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	46250
CY2023	dei	City Area Code CityAreaCode	317
CY2023	dei	Local Phone Number LocalPhoneNumber	634-3377
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	3140000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	22215512	shares
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	785522	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	872335	usd
CY2022Q4	nrom	Employee Retention Tax Credit Receivable EmployeeRetentionTaxCreditReceivable	0	usd
CY2023Q4	nrom	Employee Retention Tax Credit Receivable EmployeeRetentionTaxCreditReceivable	507726	usd
CY2022Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	824091	usd
CY2023Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	1169446	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	997868	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	965819	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	424822	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	318195	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	3032303	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	3833521	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	4351558	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	4386430	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3116030	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3130430	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	63097	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	0	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2817477	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3196993	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4713208	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4319867	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3374841	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3374841	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	934036	usd
CY2023Q4	us-gaap	Deferred Costs DeferredCosts	1403299	usd
CY2022Q4	us-gaap	Goodwill Goodwill	278466	usd
CY2023Q4	us-gaap	Goodwill Goodwill	278466	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5660155	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4930014	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	350189	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	339817	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	18343198	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	18479825	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1807035	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1284210	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	799164	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	799165	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	866667	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	1000000	usd
CY2022Q4	nrom	Warrant Liability Current WarrantLiabilityCurrent	29037	usd
CY2023Q4	nrom	Warrant Liability Current WarrantLiabilityCurrent	540650	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3501903	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3624025	usd
CY2022Q4	nrom	Loan Payable Non Current LoanPayableNonCurrent	7470900	usd
CY2023Q4	nrom	Loan Payable Non Current LoanPayableNonCurrent	6133691	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	622864	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	575000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5103286	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4378927	usd
CY2022Q4	us-gaap	Deferred Revenue And Credits Noncurrent DeferredRevenueAndCreditsNoncurrent	934036	usd
CY2023Q4	us-gaap	Deferred Revenue And Credits Noncurrent DeferredRevenueAndCreditsNoncurrent	1577299	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14131086	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	12664917	usd
CY2022Q4	us-gaap	Liabilities Liabilities	17632989	usd
CY2023Q4	us-gaap	Liabilities Liabilities	16288942	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22215512	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	24819736	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	24840126	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24109527	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22649243	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	710209	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2190883	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18343198	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18479825	usd
CY2022	nrom	Revenue From Company Owned Restaurants RevenueFromCompanyOwnedRestaurants	9704169	usd
CY2023	nrom	Revenue From Company Owned Restaurants RevenueFromCompanyOwnedRestaurants	8744158	usd
CY2022	nrom	Revenue From Company Owned Restaurants Nontraditional RevenueFromCompanyOwnedRestaurantsNontraditional	712517	usd
CY2023	nrom	Revenue From Company Owned Restaurants Nontraditional RevenueFromCompanyOwnedRestaurantsNontraditional	934662	usd
CY2022	nrom	Revenue Recognition Services Franchise RevenueRecognitionServicesFranchise	4002824	usd
CY2023	nrom	Revenue Recognition Services Franchise RevenueRecognitionServicesFranchise	4665187	usd
CY2022	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	33255	usd
CY2023	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	29567	usd
CY2022	us-gaap	Revenues Revenues	14452765	usd
CY2023	us-gaap	Revenues Revenues	14373574	usd
CY2022	nrom	Restaurant Expenses Company Owned Restaurants RestaurantExpensesCompanyOwnedRestaurants	8516405	usd
CY2023	nrom	Restaurant Expenses Company Owned Restaurants RestaurantExpensesCompanyOwnedRestaurants	7813176	usd
CY2022	nrom	Restaurant Expenses Company Owned Non Traditional RestaurantExpensesCompanyOwnedNonTraditional	704665	usd
CY2023	nrom	Restaurant Expenses Company Owned Non Traditional RestaurantExpensesCompanyOwnedNonTraditional	792532	usd
CY2022	nrom	Franchising Expenses Benefit FranchisingExpensesBenefit	2185751	usd
CY2023	nrom	Franchising Expenses Benefit FranchisingExpensesBenefit	231695	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	11406821	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	8837403	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	450550	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	379516	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2167678	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1548878	usd
CY2023	nrom	Defense Against Activist Shareholder DefenseAgainstActivistShareholder	168092	shares
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	14025049	usd
CY2023	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	10933889	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	427716	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	3439685	usd
CY2022	us-gaap	Interest Expense InterestExpense	1884147	usd
CY2023	us-gaap	Interest Expense InterestExpense	1744488	usd
CY2022	nrom	Gain Loss On Change In Fair Value Of Warrants GainLossOnChangeInFairValueOfWarrants	0	usd
CY2023	nrom	Gain Loss On Change In Fair Value Of Warrants GainLossOnChangeInFairValueOfWarrants	234913	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1456431	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1460284	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-142435	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1313996	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1460284	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22215512	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23599853	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2894564	usd
CY2022	nrom	Adjustment To Accumulated Deficit AdjustmentToAccumulatedDeficit	-898527	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1313996	usd
CY2022	nrom	Amortization Of Value Of Stock Options AmortizationOfValueOfStockOptions	28168	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	710209	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1460284	usd
CY2023	nrom	Amortization Of Value Of Stock Options AmortizationOfValueOfStockOptions	20390	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2190883	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1313996	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1460284	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	28168	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	20390	usd
CY2022	nrom	Gain Loss On Change In Fair Value Of Warrants GainLossOnChangeInFairValueOfWarrants	0	usd
CY2023	nrom	Gain Loss On Change In Fair Value Of Warrants GainLossOnChangeInFairValueOfWarrants	234913	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	450550	usd
CY2023	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	379516	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	492427	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	520533	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	123992	usd
CY2023	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	643271	usd
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	123992	usd
CY2023	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	469263	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	-18552	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	-5783	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-142435	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	nrom	Increase Decreasein Employee Retention Tax Credit IncreaseDecreaseinEmployeeRetentionTaxCredit	0	usd
CY2023	nrom	Increase Decreasein Employee Retention Tax Credit IncreaseDecreaseinEmployeeRetentionTaxCredit	507726	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-52216	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	345373	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3783	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-32049	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	9514	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-106627	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-122804	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-10372	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	334595	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-522825	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	29584	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1568551	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	507575	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13825	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-507575	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	13825	usd
CY2022	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	0	usd
CY2023	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	1445563	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	50000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1495563	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-477991	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	86813	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1263513	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	785522	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	785522	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	872335	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Use of Estimates: The preparation of the consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. In 2020, in light of the additional uncertainty created as a result of the COVID-19 pandemic, the Company decided to create a reserve for collectability on all long-term franchisee receivables. The Company will continue to pursue collection where circumstances are appropriate and all collections of these receivables in the future will result in additional income at the time received or otherwise secured. The Company evaluates its property and equipment and related costs periodically to assess whether any impairment indications are present, including recurring operating losses and significant adverse changes in legal factors or business climate that affect the recovery of recorded value. If any impairment of an individual asset is evident, a loss would be provided to reduce the carrying value to its estimated fair value. </p>
CY2023Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	373013	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	278000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3400000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1313996	usd
CY2022	nrom	Weighted Average Number Of Common Shares Outstanding Basic WeightedAverageNumberOfCommonSharesOutstandingBasic	22215512	shares
CY2022	nrom	Stock Dilution Denominator StockDilutionDenominator	47038	shares
CY2022	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-1251496	usd
CY2022	nrom	Weighted Average Number Of Common Shares Outstanding Diluted WeightedAverageNumberOfCommonSharesOutstandingDiluted	23512550	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1460284	usd
CY2023	nrom	Weighted Average Number Of Common Shares Outstanding Basic WeightedAverageNumberOfCommonSharesOutstandingBasic	22215512	shares
CY2023	nrom	Stock Dilution Denominator StockDilutionDenominator	134341	shares
CY2023	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	1517784	usd
CY2023	nrom	Weighted Average Number Of Common Shares Outstanding Diluted WeightedAverageNumberOfCommonSharesOutstandingDiluted	23599853	shares
CY2023	nrom	Discription Of First Established Under The Cares Act DiscriptionOfFirstEstablishedUnderTheCaresAct	the tax credit was equal to 50% of the qualified wages an eligible employer paid to employees after March 12, 2020 and before January 1, 2021. The credit was also limited to a maximum annual per employee credit of $5,000. The credit was then extended through June 30, 2021 by the Tax Payer Certainty and Disaster Relief Act (“Relief Act”) (Division EE of the Consolidated Appropriations Act). The Relief Act modified the credit to be 70% of up to $10,000 of qualified wages per quarter in 2021 through June 30, 2021
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1718000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1718000	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	258000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	157861	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	178372	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	27086	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	33146	usd
CY2023Q4	nrom	Equipment Inventory EquipmentInventory	780872	usd
CY2022Q4	nrom	Equipment Inventory EquipmentInventory	786350	usd
CY2023Q4	us-gaap	Other Inventory OtherInventory	965819	usd
CY2022Q4	us-gaap	Other Inventory OtherInventory	997868	usd
CY2023	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	122000	usd
CY2023	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	218000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4386430	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4351558	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3130430	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3116030	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	0	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	63097	usd
CY2023Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	7516860	usd
CY2022Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	7530685	usd
CY2023Q4	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	3196993	usd
CY2022Q4	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	2817477	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4319867	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4713208	usd
CY2023Q4	nrom	Line Of Credit Principal LineOfCreditPrincipal	7506704	usd
CY2023Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	373013	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	7133691	usd
CY2023	us-gaap	Revenue Recognition Services Royalty Fees RevenueRecognitionServicesRoyaltyFees	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 7: Royalties and Fees</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Approximately $293,500 and $203,310 are included in 2022 and 2023, respectively, for amortized initial fees in the Consolidated Statements of Operations. Also included in royalties and fees were approximately $61,000 and $123,000 in 2022 and 2023, respectively, for equipment commissions. Most of the cost for the services required to be performed by the Company are incurred prior to the initial fee income being recorded which is based on contractual liability for the franchisee.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In conjunction with the development of Noble Roman’s Pizza and Tuscano’s Italian Style Subs, the Company has devised its own recipes for many of the ingredients that go into the making of its products (“Proprietary Products”). The Company contracts with various manufacturers to manufacture its Proprietary Products in accordance with the Company’s recipes and formulas and to sell those products to authorized distributors at a contract price which includes an allowance for use of the Company’s recipes. The manufacturing contracts also require the manufacturers to hold those allowances in trust and to remit those allowances to the Company on a periodic basis, usually monthly. The Company recognizes those allowances in revenue as earned based on sales reports from the distributors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the 12-month period ended December 31, 2023 there were no company-operated or franchised Craft Pizza & Pub restaurants opened or closed. During that period there were 61 new non-traditional outlets opened and six non-traditional outlets closed.</p>
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4930014	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	799165	usd
CY2023Q4	us-gaap	Lease Deposit Liability LeaseDepositLiability	4378927	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	5178092	usd
CY2023Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	2766000	usd
CY2023Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1100000	usd
CY2023Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	5200000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3400000	usd
CY2023	us-gaap	Gain Loss On Sale Of Leased Assets Net Operating Leases GainLossOnSaleOfLeasedAssetsNetOperatingLeases	17700000	usd
CY2023	nrom	Income Tax Description IncomeTaxDescription	The net operating loss carry-forward would indicate a deferred asset of $4.4 million compared to the balance sheet amount of $3.4 million, therefore no income tax was recorded for 2023 as it was offset fully against net operating losses at a tax rate of 24%. No temporary differences were noted. In effect, we have a reserve in the deferred tax asset account of $1.0 million.
CY2023Q4	nrom	Outstanding Principal Balance OutstandingPrincipalBalance	575000	usd
CY2023Q4	nrom	Convertible Note Common Stock Price Per Shares ConvertibleNoteCommonStockPricePerShares	0.50
CY2023	nrom	Warrants Purchase Shares WarrantsPurchaseShares	625000	shares
CY2023Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.30
CY2022	nrom	Warrants Purchase Shares WarrantsPurchaseShares	100000	shares
CY2023	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	2250000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2679001	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.20	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0168	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0282	pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4855167	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	520000	shares
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	59000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5316167	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2076167	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3240000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1041500	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	520000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	327500	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	59000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1175000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	217833	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	396168	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	560999	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.22
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	28168	usd
CY2022	nrom	Tax Benefit TaxBenefit	6873	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	20390	usd
CY2023	nrom	Tax Benefit TaxBenefit	4894	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	9522	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P36M
CY2023Q4	nrom	Aggregate Principal Amount Of Note Payable AggregatePrincipalAmountOfNotePayable	50000	usd
CY2023Q4	nrom	Warrant Purchase Shares WarrantPurchaseShares	50000	shares
CY2023	us-gaap	Repayments Of Subordinated Debt RepaymentsOfSubordinatedDebt	20000	usd
CY2023	dei	Auditor Location AuditorLocation	Margate, Florida
CY2023	dei	Auditor Firm AuditorFirmId	5036
CY2023	dei	Auditor Name AuditorName	Assurance Dimensions

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001654954-24-006563-index-headers.html	Edgar Link	pending
0001654954-24-006563-index.html	Edgar Link	pending
0001654954-24-006563.txt	Edgar Link	pending
0001654954-24-006563-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nrom-20231231.xsd	Edgar Link	pending
nrom_10k.htm	Edgar Link	pending
nrom_10kimg3.jpg	Edgar Link	pending
nrom_10kimg4.jpg	Edgar Link	pending
nrom_ex311.htm	Edgar Link	pending
nrom_ex312.htm	Edgar Link	pending
nrom_ex321.htm	Edgar Link	pending
nrom_ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
nrom-20231231_cal.xml	Edgar Link	unprocessable
nrom-20231231_def.xml	Edgar Link	unprocessable
nrom-20231231_pre.xml	Edgar Link	unprocessable
nrom_10k_htm.xml	Edgar Link	completed
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
nrom-20231231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NROM
NOBLE ROMANS INC Stock $nrom

2024 Q1 Form 10-K Financial Statement

#000165495424006563 Filed on May 17, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NROM NOBLE ROMANS INC Stock $nrom

2024 Q1 Form 10-K Financial Statement

#000165495424006563 Filed on May 17, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NROM
NOBLE ROMANS INC Stock $nrom